APA

Georgiou G., Efthymiou A., Vardounioti I., Boutsikas G., Angelopoulou M. K., Vassilakopoulos T. P., Kyrtsonis M., Plata E., Tofas P., Bitsani A., Bartzi V., Pessach I., Dimou M. & Panayiotidis P. (20120604). Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib. : Leukemia.

Chicago

Georgiou G, Efthymiou A, Vardounioti I, Boutsikas G, Angelopoulou M K, Vassilakopoulos T P, Kyrtsonis M-C, Plata E, Tofas P, Bitsani A, Bartzi V, Pessach I, Dimou M and Panayiotidis P. 20120604. Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib. : Leukemia.

Harvard

Georgiou G., Efthymiou A., Vardounioti I., Boutsikas G., Angelopoulou M. K., Vassilakopoulos T. P., Kyrtsonis M., Plata E., Tofas P., Bitsani A., Bartzi V., Pessach I., Dimou M. and Panayiotidis P. (20120604). Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib. : Leukemia.

MLA

Georgiou G, Efthymiou A, Vardounioti I, Boutsikas G, Angelopoulou M K, Vassilakopoulos T P, Kyrtsonis M-C, Plata E, Tofas P, Bitsani A, Bartzi V, Pessach I, Dimou M and Panayiotidis P. Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib. : Leukemia. 20120604.